Complimentary Pass Available for Qualified Registrants. Limited quantity available.
Must be Government, Academia, Pharma, Biotech, or Regulatory to Qualify | In-Person Only
(Offer not valid on prior registrations.)
EXHIBIT HALL & KEYNOTE PASS
WEDNESDAY, APRIL 2 | 4:40 – 6:10 pm
PLENARY KEYNOTE PRESENTATION: From Bytes to Breakthroughs: Next-Generation AI Driving the Future of Life Sciences and Healthcare
PANEL MODERATOR:
Abbie Celniker, PhD, Partner, Third Rock Ventures LLC
Next-Generation AI has the potential to revolutionize life sciences by delivering unprecedented insights, automation, and efficiency. But what will those industry transformations look like? This keynote panel convenes leaders from biopharma, healthcare, and emerging tech who are applying AI—generative models and beyond—to accelerate drug discovery, diagnostics, and patient care. Panelists will share real-world case studies, discuss overcoming both technical and organizational challenges, and explore how AI is evolving from predictive tools to autonomous, decision-making systems. Look beyond the hype to uncover where AI is making a tangible impact today and where the next frontiers of innovation lie.
PANELISTS:
Tala Fakhouri, PhD, MPH, Associate Director for Data Science and AI Policy, FDA (participating virtually)
Per Greisen, PhD, President, BioMap
Sofia Guerra, Vice President, Bessemer Venture Partners
Subha Madhavan, PhD, Vice President and Head, AI/ML, Quantitative and Digital Sciences, Pfizer Inc.
Sonya Makhni, MD, Medical Director, Mayo Clinic Platform
EXHIBIT HALL & KEYNOTE PRESENTATION SCHEDULE:
WEDNESDAY, APRIL 2
6:10 – 7:25 pm Exhibit Hall Open
4:40 – 6:10 pm Plenary Keynote Presentation
6:10 – 7:25 pm Welcome Reception in the Exhibit Hall with Poster Viewing
THURSDAY, APRIL 3
9:30 am – 5:45 pm Exhibit Hall Open
8:00 – 9:30 am Plenary Keynote Presentation
9:30 – 10:15 am Coffee & Networking in the Exhibit Hall with Poster Viewing
10:05 am Raffle Drawing: Apple Air Tags
1:35 – 2:25 pm Refreshments & Networking in the Exhibit Hall with Poster Viewing
4:30 – 5:45 pm Best of Show Awards Reception in the Exhibit Hall with Poster Viewing
5:30 pm Raffle Drawing: Apple AirPods
FRIDAY, APRIL 4
9:45 am – 2:30 pm Exhibit Hall Open
8:00 – 8:20 am Innovative Practices Awards
8:20 – 9:45 am Plenary Keynote Presentation
9:45 – 10:30 am Coffee Break in the Exhibit Hall with Poster Viewing and Poster Award Winner Announcement
1:50 – 2:30 pm Refreshment Break in the Exhibit Hall with Poster Viewing
2:20 pm Raffle Drawing: Ring Doorbell
Please note: exhibit hall passes do not have access to the full agenda or event app. A main conference registration is required to unlock everything Bio-IT World has to offer.
**Exhibit Hours Subject to Change**
THURSDAY, APRIL 3 | 8:00 – 9:30 am
PLENARY KEYNOTE PRESENTATION: Data and Computing Infrastructure for the Life Sciences: Best Practices, Observations, and Lessons Learned
Chris Dwan, Independent Consultant, Dwan, LLC
This talk will provide practical, real-world advice based on Dwan's quarter century of experience designing and implementing high-performance computing and large-scale data systems for health care and the life sciences. Topics will include network architectures, cloud vs. "terrestrial" infrastructure, practical data strategies, information security, quality and compliance from R&D to the clinic, differentiated computing platforms, human and organizational factors, and of course AI.
PLENARY KEYNOTE PRESENTATION: Generative AI, Aging Research and Robotics as a Platform for Drug Discovery: From Hype to Clinical Efficacy
Alex Zhavoronkov, PhD, Founder & CEO, Insilico Medicine
FRIDAY, APRIL 4 | 8:00 – 9:45 am
PLENARY KEYNOTE AWARDS PRESENTATIONS: Innovative Practices Awards: Excellence in Technological Innovation
Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News
The Innovative Practices Awards recognizes and celebrates technology innovation in the life sciences. Bio-IT World is currently accepting entries for the 2025 Innovative Practices Awards, a competition designed to recognize partnerships and projects pushing our industry forward. Winners will be announced in early-March 2025, recognized during the Friday, April 4 Plenary Keynote Program, and scheduled to give a podium presentation about their project during the conference. For more details about the Awards and to submit an application, visit www.bio-itworldexpo.com/innovativepractices.
PLENARY KEYNOTE PRESENTATION: The Longitude Prize on ALS: A Groundbreaking Global Prize Harnessing the Power of AI to Drive Treatment for ALS
Tris Dyson, Founder and Managing Director, Challenge Works
Jeff Rothstein, MD, PhD, Professor of Neurology and Neuroscience, Director, Brain Science Institute, Johns Hopkins University
The Longitude Prize series brings together the brightest minds to solve the world's most challenging innovation problems. The Longitude Prize on ALS, launching in June 2025, will bring together computational biologists, neurodegenerative researchers and AI-driven biotech globally to uncover novel therapeutic targets for ALS.
PLENARY KEYNOTE PRESENTATION: Scaling Genomic Medicine: Transforming Newborn Screening through Informatics and Innovation
Robert C. Green, MD, MPH, Professor and Director of Genomes2People Research, Mass General Brigham, Broad Institute, Ariadne Labs and Harvard Medical School
The BabySeq Project has pioneered the integration of genomic sequencing into newborn and childhood screening, uncovering unexpected risk variants and transforming healthcare delivery. This keynote explores the groundbreaking progress in genomic medicine, featuring real-world stories of families impacted by these discoveries. Learn about the informatics challenges and innovative solutions required to scale genomic screening for national and global implementation, reshaping the future of precision medicine.
PLENARY KEYNOTE PRESENTATION: Unlocking the Power of Machine Learning and Data-at-Scale to Deliver with Speed the Best Therapeutic Candidates
Justin M. Scheer, PhD, Vice President In Silico Discovery & Head, Molecular Computational Team, Johnson & Johnson Innovative Medicine
The challenges of high costs, lengthy timelines, and significant attrition have prompted our industry to integrate AI/ML into all aspects of the business. This presentation highlights J&J's strategic investments in AI/ML technologies to enhance the drug discovery processes, including molecule design and optimization. By investing in these technologies with a modality agnostic approach, J&J aims to tackle the hardest targets in drug discovery, ultimately increasing the success rate of delivering better molecules faster.
Complimentary Pass Available to a Limited Number of Qualified Registrants.
Must be Government, Academia, Pharma, Biotech, or Regulatory to Qualify | In-Person Only
(Offer not valid on prior registrations.)
Please note: Exhibit hall passes do not have access to the full agenda or event app. A main conference registration is required to unlock everything Bio-IT World has to offer.